Daniel Faga's Net Worth
$35.3 Million
Who is Daniel Faga?
Daniel Faga has an estimated net worth of $35.3 Million. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., ANAPTYSBIO, INC, and Spark Therapeutics, Inc..
SEC CIK
Daniel Faga's CIK is 0001673528
Past Insider Trading and Trends
2017 was Daniel Faga's most active year for acquiring shares with 10 total transactions. Daniel Faga's most active month to acquire stocks was the month of December. 2017 was Daniel Faga's most active year for disposing of shares, totalling 18 transactions. Daniel Faga's most active month to dispose stocks was the month of December. 2019 saw Daniel Faga paying a total of $4,238,292.50 for 152,250 shares, this is the most they've acquired in one year. In 2024 Daniel Faga cashed out on 521,097 shares for a total of $11,043,925.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mirati Therapeutics, Inc. (MRTX) No price found
EVP, Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$154.35 | -$107,267.00 | 30.64K |
Scheduled
|
Feb 2
| ||
Form 4
| +29.74% | 7.02K |
—
|
—
| 30.64K |
Jan 15
| |||
Form 4
| -10.00% | -2.63K |
$216.33 | -$567,853.97 | 23.61K |
Jan 7
| |||
Form 4
|
∞
| 26.24K |
—
|
—
| 26.24K |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANAPTYSBIO, INC (ANAB) Snapshot price: $35.9
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
| -55.27% | -496.38K |
$21.95 | -$10,894,177.62 | 401.65K |
Mar 22 - Mar 26
| |||
Form 4
| +1.24% | 10.98K |
$21.81 | -$149,747.46 | 898.03K |
Jan 6 - Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
∞
| 887.04K |
—
|
—
| 887.04K |
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spark Therapeutics, Inc. No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.83K |
$114.50 | -$4,445,806.00 |
0
|
Dec 17
| |||
Form 4
| +863.00% | 34.8K |
$77.34 | -$3,469,215.71 | 38.83K |
Mar 25
| |||
Form 4
| +259.68% | 2.91K |
$45.08 | -$71,632.12 | 4.03K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
∞
| 1.12K |
$50.55 | -$44,433.45 | 1.12K |
Jan 18
| |||
Form 4
|
—
|
0
|
$59.29 | -$325,050.00 |
0
|
Scheduled
|
Oct 20 - Oct 24
| ||
Form 4
|
—
|
0
|
$61.31 | -$71,070.00 |
0
|
Scheduled
|
Sep 19
| ||
Form 4
|
—
|
0
|
$60.06 | -$269,289.00 |
0
|
Scheduled
|
Sep 12
| ||
Form 4
|
—
|
0
|
$61.32 | -$142,185.00 |
0
|
Scheduled
|
Sep 7
| ||
Form 4
|
—
|
0
|
$53.81 | -$97,140.00 |
0
|
Scheduled
|
Jul 24
| ||
Form 4
|
—
|
0
|
$50.17 | -$112,905.00 |
0
|
Scheduled
|
Jun 29
| ||
Form 4
|
—
|
0
|
$47.26 | -$86,760.00 |
0
|
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||